全文获取类型
收费全文 | 5213篇 |
免费 | 352篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 120篇 |
妇产科学 | 66篇 |
基础医学 | 810篇 |
口腔科学 | 116篇 |
临床医学 | 365篇 |
内科学 | 1374篇 |
皮肤病学 | 268篇 |
神经病学 | 344篇 |
特种医学 | 112篇 |
外科学 | 490篇 |
综合类 | 21篇 |
一般理论 | 1篇 |
预防医学 | 261篇 |
眼科学 | 165篇 |
药学 | 397篇 |
中国医学 | 15篇 |
肿瘤学 | 621篇 |
出版年
2024年 | 4篇 |
2023年 | 29篇 |
2022年 | 78篇 |
2021年 | 165篇 |
2020年 | 103篇 |
2019年 | 100篇 |
2018年 | 164篇 |
2017年 | 124篇 |
2016年 | 153篇 |
2015年 | 118篇 |
2014年 | 174篇 |
2013年 | 251篇 |
2012年 | 371篇 |
2011年 | 382篇 |
2010年 | 214篇 |
2009年 | 198篇 |
2008年 | 354篇 |
2007年 | 384篇 |
2006年 | 343篇 |
2005年 | 335篇 |
2004年 | 336篇 |
2003年 | 295篇 |
2002年 | 284篇 |
2001年 | 63篇 |
2000年 | 45篇 |
1999年 | 58篇 |
1998年 | 61篇 |
1997年 | 60篇 |
1996年 | 38篇 |
1995年 | 37篇 |
1994年 | 20篇 |
1993年 | 30篇 |
1992年 | 18篇 |
1991年 | 12篇 |
1990年 | 18篇 |
1989年 | 27篇 |
1988年 | 16篇 |
1987年 | 15篇 |
1986年 | 16篇 |
1985年 | 8篇 |
1984年 | 13篇 |
1983年 | 7篇 |
1982年 | 10篇 |
1981年 | 4篇 |
1979年 | 13篇 |
1977年 | 3篇 |
1976年 | 5篇 |
1973年 | 3篇 |
1969年 | 6篇 |
1967年 | 4篇 |
排序方式: 共有5585条查询结果,搜索用时 15 毫秒
81.
Risa Konishi Ryota Tanaka Sae Inoue Yuki Ichimura Toshifumi Nomura Naoko Okiyama 《The Journal of dermatology》2022,49(1):118-123
Dermatomyositis, an idiopathic inflammatory myopathy, is characterized by cutaneous itchy manifestations, which are frequently refractory and recurrent even after intensive immunosuppressive treatments. To evaluate the effectiveness and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in treating skin-dominant dermatomyositis in which myositis and interstitial lung disease are absent or in remission, we performed this prospective, single-arm, interventional study. A total of five Japanese patients (one male and four females, median [range] age, 64 [37–71] years) with refractory dermatomyositis-associated cutaneous manifestations were recruited and treated with a 12-week course of oral apremilast. Among five enrolled patients, three experienced diarrhea with full-dose apremilast (30 mg twice daily), two of whom withdrew from the study and recovered quickly afterwards. A total of three evaluable female patients (median [range] age, 65 [64–71] years) received apremilast treatment for 12 weeks. A 39.4% reduction from baseline Cutaneous Dermatomyositis Disease Area and Severity Index total activity score, but not the damage score, at week 12 was observed in all three patients. Visual analog scale of itching, and quality of life by Dermatology Life Quality Index were slightly improved in one and two apremilast-treated patients, respectively. As apremilast was effective, with expected and recoverable digestive adverse events (diarrhea), in patients with refractory and recurrent dermatomyositis-associated cutaneous manifestations in this first phase Ib study, it can be suggested as a possible treatment when aggressive immunosuppressive therapies with high-dose systemic corticosteroid and/or immunosuppressive agents for other manifestations, myositis, and interstitial lung disease, are not required. 相似文献
82.
Takaharu Ikeda Tamihiro Kawakami Yoshihiro Arimura Naoko Ishiguro Akihiro Ishizu Fuyu Ito Toshiko Ito-Ihara Naoko Okiyama Sachiko Ono Kazuo Suzuki Koji Sugawara Mariko Seishima Masanari Kodera Maiko Tanaka Minoru Hasegawa Fukumi Furukawa Yukie Yamaguchi Ayumi Yoshizaki Revised Committee for guidelines for the management of vasculitis vascular disorders of the Japanese Dermatological Association 《The Journal of dermatology》2020,47(5):534-537
We developed a questionnaire to examine the findings of cutaneous arteritis among dermatological specialists experienced in vasculitis as certified by the Committee for guidelines for the management of vasculitis and vascular disorders of the Japanese Dermatological Association. We sent a questionnaire to 12 dermatological facilities identified through the revised Committee for guidelines for the management of vasculitis and vascular disorders of the Japanese Dermatological Association. Retrospective data obtained from 84 patients at the 12 dermatological facilities between 2012 January 2016 December were evaluated. The 84 patients were categorized into two groups, a systemic steroid treatment group (group 1, n = 52) and a no systemic steroid treatment group (group 2, n = 32). C-reactive protein in group 1 patients was significantly higher than that in group 2 patients. Frequency of fever, arthritis, myalgia- and peripheral neuropathy in group 1 was significantly higher than that in group 2. We propose that these symptoms could serve as early markers for the transfer from cutaneous arteritis to systemic polyarteritis nodosa. We further suggest that patients who are subsequently associated with cerebral hemorrhage and infarction, who are originally diagnosed as having cutaneous arteritis, could progress to systemic polyarteritis nodosa. The study demonstrated that it is important for dermatologists to detect these findings early in order to establish an accurate diagnosis and a timely treatment. 相似文献
83.
Shinichiro Muro Hironari Kato Etsuji Ishida Toru Ueki Masakuni Fujii Ryo Harada Hiroyuki Seki Ken Hirao Masaki Wato Yutaka Akimoto Masahiro Takatani Hirofumi Tsugeno Jiro Miyaike Tatsuya Toyokawa Mamoru Nishimura Naoko Yunoki Hiroyuki Okada 《Journal of gastroenterology and hepatology》2020,35(1):37-42
84.
85.
86.
87.
Negative‐pressure closure was superior to tie‐over technique for stabilization of split‐thickness skin graft in large or muscle‐exposing defects: A retrospective study
下载免费PDF全文
![点击此处可从《The Journal of dermatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Yoshiyuki Nakamura Yasuhiro Fujisawa Yosuke Ishitsuka Ryota Tanaka Hiroshi Maruyama Naoko Okiyama Rei Watanabe Manabu Fujimoto 《The Journal of dermatology》2018,45(10):1207-1210
Skin grafts are frequently used for the reconstruction of skin defects, and optimal stabilization of the graft is essential for successful reconstruction. Although the tie‐over technique has been widely used as a standard method in Japan, we sometimes encounter cases with significant graft loss due to suboptimal stabilization of the graft. Reported risk factors for increased graft loss include the following: defects of a large size, with muscle exposure, and located in the trunk and extremities. Recent studies have demonstrated the usefulness of negative‐pressure closure (NPC) for the stabilization of skin grafts due to the uniform pressure it provides across the graft. Therefore, since March 2017, we have used NPC for skin graft stabilization in patients with defects in the trunk and extremities of more than 10 cm in size or with muscle exposure. We carried out a retrospective comparative study of the outcome of the conventional tie‐over technique versus NPC. Mann–Whitney U‐test revealed that NPC showed significantly higher graft survival rate than tie‐over method (P = 0.0012). In addition, NPC showed a tendency toward shorter operative times (from skin graft harvest to the completion of the graft stabilization) than the tie‐over method (P = 0.0931). These results suggest that NPC may be superior to the tie‐over method for stabilization of skin grafts especially in large or muscle‐exposing defects in the trunk or extremities. 相似文献
88.
89.
90.